CatalystFDA/Bio

Teva: 'Hold' On FDA Approval Of Weltruza And Pivot To Growth Strategy

FDA approval of Weltruza and pivot to growth strategy drive Teva outlook.

What changed

FDA approval of Weltruza and pivot to growth strategy drive Teva outlook.

Why it matters

FDA approval of Weltruza and pivot to growth strategy drive Teva outlook. — impact context not separately stored; see What changed.

Sources